Eckert & Ziegler Strahlen- und Medizintechnik AG announced that to expand its manufacturing capacities, Eckert & Ziegler plans to invest around ?10 million in its own site in Wilmington, MA. Eckert & Ziegler is thus positioning itself as an important supplier of lutetium-177 in the rapidly growing radioligand therapy market.